Four drugs, namely budesonide, fluoxetine, hesperidin and imatinib, show interactions with the genes associated with the susceptibility to both IPF-BMI and IPF-CAD (i.e., BRSK2, CRHR1, ULK3). This evidence concerns the gene ULK3 and coronary artery disorder.